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Research in context 1 
Evidence before this study 2 
A search on PubMed with the terms “genetic”, “cluster”, “HIV”, “epidemiology” and “network” in 3 
January 2017 returned 25 articles. We focused our attention on analyses of densely sampled 4 
epidemics in Europe and North America. The present UK epidemic among men who have sex with 5 
men (MSM) arose through the introduction of subtype B viruses in the early 1980s. In contrast, in 6 
heterosexuals, the majority of viruses are non-B subtypes. Within MSM transmission networks, 7 
there is a subgroup of men who self-report as heterosexual but whose HIV genetic sequences link 8 
only to MSM. This group is very poorly understood: they are inaccessible to classical epidemiological 9 
approaches and were only revealed in the UK recently, in a single molecular epidemiology study.    10 
Added value of this study 11 
We focused on this group of self-reported heterosexual men who link only to MSM adopting a novel 12 
network based method which allowed us investigate transmission across multiple subtypes. 13 
Analysing viral sequences from over 50,000 individuals, we identified men who self-report as 14 
heterosexual in MSM HIV transmission networks (potential nondisclosed MSM), examined their 15 
position and compared them to the MSM with whom they clustered. We found that these men 16 
tended to link to each other and were not involved in rapid chains of MSM transmission. They were 17 
more likely to be non-White than the MSM they clustered with. We found more examples of 18 
heterosexual men linking heterosexuals and MSM than heterosexual women in that position, 19 
although the total number of such chains was small.  20 
Implications of all the available evidence 21 
The tendency of nondisclosed MSM in our network to link to each other indicates that they may 22 
preferentially seek out other nondisclosed MSM partners for sex.  This result aligns with conclusions 23 
from small scale interview-based studies, which found that they attend different venues to MSM. 24 
The current study is the first to characterise the behaviour of nondisclosed MSM at a national scale. 25 
Our results suggest that nondisclosed MSM may be underestimating their risk and should be 26 
encouraged to test more frequently with better targeted prevention messages. However, it should 27 
be emphasised that the extent of bridging between the heterosexual and MSM epidemics appears to 28 
be limited.  29 
Summary 30 
Background 31 
Patients who do not disclose their sexuality, for example men who do not disclose same-sex 32 
behaviour, are extremely difficult to characterise through traditional epidemiological approaches. 33 
Using a recently developed method to detect large networks of viral sequences from time-resolved 34 
trees, we have localised these men in UK transmission networks, gaining critical insights into the 35 
behaviour of this group.  36 
Methods  37 
We obtained HIV pol sequences from the UK HIV Drug Resistance Database (UKRDB), a central 38 
repository for resistance tests performed as part of routine clinical care throughout the UK. 39 
Sequence data are linked to demographic and clinical data held by the UK Collaborative HIV Cohort study 40 
and the national HIV/AIDS Reporting System database. Initially we reconstructed maximum likelihood 41 
phylogenies from sequences from over 50,000 individuals in the UK. Sequences were selected for 42 
time-resolved analysis in BEAST if they were clustered with at least one other sequence at a genetic 43 
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distance ≤4.5% with support ≥ 90%. We used time-resolved phylogenies to create networks by 1 
linking together nodes if sequences shared a common ancestor within the previous 5 years. We 2 
identified potential nondisclosed MSM (pnMSM) as self-reported heterosexual men who clustered 3 
only with men. We measured the network position of pnMSM, including betweenness (a measure of 4 
connectedness and importance) and assortativity ((the propensity for nodes sharing attributes to 5 
link). 6 
Findings 7 
14,405 individuals were represented in the network, including 8,452 MSM, 1743 heterosexual 8 
women and 1341 male heterosexuals. 249 pnMSM were identified (18.6% of all clustered 9 
heterosexual men). pnMSM were more likely to be Black-African (p<0.0001) and were slightly older 10 
(39.00 vs. 36.38 p=0.002) than the MSM they clustered with. Betweenness centrality was lower for 11 
pnMSM than for MSM (1.31 vs 2.24, p=0.002), indicating that they were in peripheral positions in 12 
MSM clusters. Assortativity by risk group was higher than expected (0.037 vs - 0.037, p=0.01) 13 
signifying that pnMSM linked to each other. We found that self-reported male heterosexuals were 14 
more likely than heterosexual women to link MSM and heterosexuals (Fisher’s exact test; p=0.0004; 15 
OR 2.24) but the number of such transmission chains was small (only 54 in total compared to 32 in 16 
women). 17 
Interpretation 18 
We have shown that pnMSM are a subgroup distinct from both MSM and from male heterosexuals. 19 
Male heterosexuals are the group most likely to be diagnosed in late stage disease, and nondisclosed 20 
MSM may put female partners at higher risk. Thus, pnMSM require specific consideration to ensure 21 
they are included in public health interventions. 22 
Funding 23 
NIH GM110749 (MIDAS). 24 
Introduction 25 
Men who have sex with men (MSM) are the group at highest risk for HIV infection, with higher HIV 26 
prevalence than the general population in every world region (1). In the UK, MSM account for half of 27 
those living with HIV despite increased testing and uptake of treatment (2). 28 
Among MSM, those who do not disclose their same-sex behaviour for fear of stigmatisation, 29 
rejection or prejudice (3) are more likely to exhibit risky sexual behaviour, for example not using 30 
condoms (4), and are more likely to have sex with women (5). Insights into the behaviour of 31 
nondisclosed MSM are difficult to obtain but central to our understanding of HIV transmission. 32 
Phylogenetic analysis of viral sequences has provided a valuable route to elucidating transmission 33 
dynamics (6). Phylogenies can be combined with epidemiological, demographic and behavioural 34 
data to elucidate spread of HIV through time, geographical regions and different risk groups (7). 35 
Phylogenies have been used to investigate the role of age, disease stage, viral load and treatment on 36 
transmission (8). 37 
In the UK, analysis of subtype B viruses demonstrated the existence of six independent transmission 38 
chains among MSM following separate introductions in the 1980s (9). MSM were much more likely 39 
than heterosexuals to fall within groups of closely linked infections, or clusters (6, 10). Within 40 
clusters, 25% of transmissions happen within six months of infection among MSM (6), compared to 41 
2% in heterosexuals (10). In a recent analysis we used phylogenetics to quantify the extent of 42 
nondisclosure of sex with men among heterosexual men (11). Eleven percent of heterosexual men 43 
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clustered only with MSM compared to only 5% of heterosexual women. This discrepancy suggests 1 
around 6% (1-11%) of men who report only heterosexual behaviour became infected through sex 2 
with men. The difference was most significant among Black African men, where up to 21% may have 3 
been infected by men. 4 
The structure of contact networks provides information on the process that led to their formation 5 
(12).  The transmission network is a subset of the contact network whose structure is shaped by the 6 
underlying contact network and by the transmission characteristics of the pathogen (13). Thus, an 7 
isolated node in an HIV transmission network may represent an individual who had no sexual 8 
contacts after infection or one who had many sexual contacts but never transmitted the virus. 9 
Nonetheless, aggregate differences in network characteristics between groups can reveal 10 
differences in behaviour: MSM clusters are larger than heterosexual clusters (6, 10), indicating on 11 
average more sexual partners and more onward transmission events. 12 
Here we have further exploited our network reconstruction methodology (14) in order to describe 13 
the network positions of nondisclosed MSM for the first time. We hypothesised that their position 14 
within network clusters would differ from that of the MSM with whom they cluster, revealing 15 
differences in sexual or transmission behaviour. 16 
Methods 17 
1. Study population 18 
We obtained 63,065 aligned HIV pol sequences, each representing a distinct HIV positive individual, 19 
from the UK HIV Drug Resistance Database (UKRDB; http://www.hivrdb.org; sequences up to mid-20 
2013). The UKRDB was established in 2001 as a central repository for resistance tests performed as 21 
part of routine clinical care throughout the UK. Clinical centres that contribute to the UKRDB are 22 
listed in the Appendix, p5. Sequences covering protease and 900 bases of reverse transcriptase are 23 
received from laboratories. Sequences are aligned by the database managers at UKRDB through the 24 
Stanford University Genotypic Resistance Interpretation Algorithm (hivdb.stanford.edu). Sequence 25 
data are linked to demographic and clinical patient data held by the UK Collaborative HIV Cohort 26 
study (15) and the national HIV/AIDS Reporting System database held at Public Health England (16). 27 
After linking sequences to age, sex, risk group, ethnicity, avidity score and stage of infection, the 28 
data were anonymised. Infections are classified as recent (<155 days) if their avidity is <80%. UKRDB 29 
data collection and processing is explained on the UKRDB website (http://www.hivrdb.org.uk/data-30 
collection-and-processing). We assigned subtypes using SCUEAL (17). The three most common 31 
subtypes, B (49.5%), C (24.9%), and A1 (4.5%), were analysed, comprising 50,025 individuals 32 
diagnosed between 1997 and 2013, for each of whom we used the earliest available sequence. The 33 
London Multicentre Research Ethics Committee gave ethical approval for non-consented studies of 34 
anonymised data (MREC/01/2/10). 35 
In parallel, we retrieved over 130,000 pol (HXB2 positions 2253-3870, minimum length 900bp) 36 
sequences of HIV subtypes A1, B, and C, from the Los Alamos National Laboratory (LANL) database 37 
(January 2014). To limit the size of alignments, we selected the ten closest non-UK sequences to 38 
each UK sequence. All sequences were stripped of 44 sites associated with drug resistance (18). 39 
2. Phylogenetic analysis 40 
For each subtype, we reconstructed phylogenies in RaxMLv8.2 with 100 bootstrap replicates (19). 41 
We considered 100 bootstraps to be sufficient because the maximum likelihood phylogeny was the 42 
first step towards deciding whether to include sequences in a time-resolved analysis. We identified 43 
clusters in phylogenies using Cluster Picker v1.2.3 if they were supported by a bootstrap ≥90% and 44 
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had a maximum genetic distance ≤4.5% (6), with gaps ignored in pairwise comparisons and 1 
ambiguities counted as mismatches. The phylogenetic relationships between clustered sequences 2 
were then time-resolved in BEASTv1.8 (20). 3 
We sorted previously identified clusters into pools of up to 300 sequences so that all sequences from 4 
the same cluster were analysed together (14), but limiting the size of datasets. Seventy-three pools 5 
were created altogether. For each pool, we generated summary statistics, including the number of 6 
sequences, the number of (RaxML-identified) clusters and the breadth of years covered (the 7 
difference between the oldest and the youngest sequence). We tested settings in two pools each of 8 
subtype B and subtype C sequences with maximum breadth of sequence dates (12 years). We 9 
compared clock (strict and relaxed) and demographic models (constant, exponential, logistic, 10 
Bayesian skyline and Bayesian skyride) in the test pools. We used an SRD06 substitution model as 11 
codon models give the best fit to HIV pol sequence data (21). A normally distributed molecular clock 12 
rate prior with a mean of 2.55 x 10-3 was used (9). The best model was selected as the skyride with 13 
an uncorrelated lognormal clock by means of its Bayes Factor (the ratio of the marginal likelihoods of 14 
two models), as estimated through path sampling. Chains were run for 100,000,000 generations in 15 
duplicate, checked for convergence in Tracer v1.6 and combined. We generated maximum clade 16 
credibility trees in Tree Annotator v1.8.4.  17 
We reconstructed networks from phylogenies as previously described (14) using R scripts (available 18 
at github.com/hxnx-sam/Rcode_utils/). In brief, each sequence is represented by a node in the 19 
network and nodes are linked together (clustered) if their time to most recent common ancestor is 20 
≤5 years in the time-resolved maximum clade credibility tree. In contrast to clusters defined 21 
phylogenetically, nodes in network clusters are not all connected to each other, and clusters can 22 
contain sequences which are not monophyletic in the tree. Different depths of network 23 
reconstruction were evaluated in a previous analysis (14), and here we selected five years as a cut-24 
off for consistency with the National Survey of Sexual Attitudes and Lifestyles (NATSAL) (22). 25 
3. Procedures 26 
We constructed a multivariate logistic regression model with the outcome being either clustered in 27 
the network (1) or not (0). Subtype, sex, risk group and ethnicity were included as predictor 28 
variables, and we included terms for the interactions between variables. 29 
We conducted network analysis using the igraph v1.1 (23) and network v1.13 (24) packages in R 30 
v3.4.1. Networks for all subtypes were amalgamated and nodes were linked to demographic data. 31 
While the transmission dynamics of B and non-B subtypes are undoubtedly different in the UK (6, 32 
10), subtype was maintained as a variable associated with each node so that results could be 33 
interpreted by subtype.  34 
We classified self-reported heterosexual men who clustered only with MSM and with no women as 35 
potential nondisclosed MSM (pnMSM; see results) and we compared their positions within networks 36 
to that of the MSM with whom they clustered based on their centrality and linkage (Figure 1). 37 
Centrality measures (degree, betweenness centrality and eigenvector centrality) quantify how 38 
important a node is in keeping a network connected. Degree is the number of edges connected to a 39 
node. Betweenness centrality is the number of shortest paths linking every pair of nodes that go 40 
through the node examined. Eigenvector centrality weighs the centrality of neighbouring nodes so 41 
that a node with high eigenvector centrality may not have high degree itself but is central to the 42 
structure of the network. Betweenness and eigenvector centrality measure how connected a node 43 
is, and how important that node is to the network. Eigenvector centrality is more conservative than 44 
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degree and betweenness and is less affected by network and cluster size. Low centrality indicates 1 
that a node is peripheral to a network (Figure 1A). 2 
We evaluated the propensity for nodes to link to other nodes sharing their characteristics in order to 3 
test whether pnMSM were more likely to link to each other than to MSM (Figure 1B). This was done 4 
by calculating network assortativity as available in the network package (24). Assortativity varies 5 
between -1 (completely disassortative) and 1 (completely assortative) and is influenced by the ratio 6 
of node labels (here, MSM and HET/pnMSM). To ensure both assortative and disassortative links 7 
were possible in each cluster, we analysed only clusters comprising at least two MSM and two male 8 
self-reported heterosexuals. To generate a null distribution of expected assortativity given the 9 
relative representation of MSM and pnMSM, we randomised risk group 10,000 times across the sub-10 
network and recalculated assortativity each time. 11 
Finally, we tested whether pnMSM might link the MSM and heterosexual epidemics (Figure 1C) by 12 
counting the number of relationships they brokered between MSM and heterosexual women and 13 
comparing it to the number of relationships brokered by heterosexual women (Figure 1D). We 14 
performed a Gould-Fernandez brokerage analysis available in R (25) to count occurrences in the 15 
network of heterosexual men linking MSM and female heterosexuals, and compared this to the 16 
incidence of females linking MSM and heterosexual men (Figure 1D). This analysis was performed on 17 
the entire network as it required clusters in which females were also present. 18 
4. Data sharing 19 
As submission of the entire national cohort to public databases would permit transmission network 20 
identification and risk breaching patient confidentiality, we have followed earlier practice (6, 10) and 21 
submitted a random sample of 10% of each subtype to GenBank (accession numbers available in the 22 
online Appendix p4). The UKRDB Steering Committee encourages analysis proposals. Instructions for 23 
applying are available at http://www.hivrdb.org.uk/. 24 
5. Role of the funding source 25 
The funders of the study had no role in study design, data collection, data analysis, data 26 
interpretation, or writing of the report. The corresponding author had full access to all the data in 27 
the study and had final responsibility for the decision to submit for publication. 28 
Results 29 
The earliest sequence analysed originated from an individual sampled in January 1997, the most 30 
recent sequence analysed here originated from an individual diagnosed and sampled in July 2013 31 
(Supplementary Figure 3, Appendix p2). Of 50,025 sequences analysed, 21,053 (42.1%) sequences 32 
linked to at least one other at a genetic distance of 4.5% in the RaxML phylogeny. At a time-depth of 33 
five years, 14,405 patients shared an ancestor within 5 years and were therefore represented in the 34 
resulting network (28.8%, Table 1, Figure 2). Of 4,836 clusters, 3,344 (69.1%) comprised only two 35 
sequences, and maximum cluster size was 87 (Supplementary Figure 1, Appendix p1). 36 
Based on the logistic regression, MSM were more likely to cluster than heterosexuals (OR: 2.6, 37 
p<0.0001, Table 1), subtype B sequences were more likely to cluster than subtypes A1 and C (OR: 38 
2.8, p<0.0001) and white individuals were more clustered than Black Africans (OR: 1.9, p=0.0002). 39 
Some interactions between predictors were significant but effects were small (Supplementary Table 40 
1, Appendix p3). Subtype B, MSM risk group and white ethnicity were independently predictive of 41 
clustering even after their interactions were taken into account. 42 
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We analysed all clusters that contained one or more self-reported heterosexual men and one or 1 
more MSM but no women. We describe these men as potential nondisclosed MSM (pnMSM). There 2 
were 223 clusters comprising 955 MSM and 249 self-identified heterosexual men (Figure 3). These 3 
pnMSM represented 18.6% of a total of 1341 clustered self-reported heterosexual men. As a 4 
comparison, 131/1743 (7.5%) of clustered heterosexual women clustered only with MSM. In the 5 
present dataset, 22,296/25,492 (87.5%) MSM were infected with subtype B, while for other risk 6 
groups, only 9,353/37,671 (24.8%) were infected with subtype B (Fisher’s exact t-test, p<0.0001). 7 
We compared pnMSM to the MSM with whom they clustered: pnMSM were more likely to be Black 8 
African, less likely to be infected with subtype B and were slightly older than the MSM they clustered 9 
with (Table 2). There was no difference in the proportion of recent infections between the two 10 
groups. 11 
We wanted to test whether the position of pnMSM and MSM in the network differed because a 12 
difference in transmission network characteristics is indicative of a difference in underlying 13 
transmission dynamics. In clusters comprising MSM and pnMSM, betweenness (1.31 vs 2.24) and 14 
eigenvector centrality (0.50 vs 0.52) were significantly lower for pnMSM than for the MSM they 15 
clustered with (paired Wilcoxon signed rank test, p=0.002 and p=0.039, respectively; Table 3), 16 
indicating that pnMSM were in peripheral positions in clusters. However, mean degree was not 17 
different between MSM and pnMSM (paired Wilcoxon signed rank test, 3.02 vs 2.83, p=0.07) and so 18 
pnMSM were not less connected overall than MSM. 19 
We then investigated whether pnMSM might be more likely to link to each other in clusters, 20 
indicating that pnMSM might be more likely to partner with and be infected by other pnMSM. There 21 
were 26 clusters containing at least two MSM and at least two self-reported heterosexual men, 22 
comprising 310 MSM and 87 heterosexual men. Among the 26 clusters in the true network, the 23 
assortativity coefficient was 0.037, and an assortativity coefficient higher than this was seen in only 24 
110/10,000 of the permutations (p=0.011; simulation mean: -0.037; simulation 95% CI -0.004 - -25 
0.034; Supplementary Figure 2, Appendix p2), indicating that pnMSM linked to each other. 26 
Finally, we tested whether pnMSM might link the MSM and heterosexual epidemics. We found that 27 
self-reported heterosexual men were more likely to broker relationships between MSM and 28 
heterosexuals (Fisher’s exact test, p=0.0004; OR 2.24 95%CI 1.41-3.61) than heterosexual women 29 
but numbers were small for both categories. Of 1341 self-reported heterosexual men represented 30 
by nodes in the network, 54 (4.0%) were located in between an MSM and a heterosexual of the 31 
opposite gender. This was true for only 32/1711 (1.9%) of heterosexual women. 32 
Discussion 33 
We identified potential nondisclosed MSM in the UK epidemic and describe their position in 34 
transmission networks. In contrast to previous phylogenetic analyses, which were limited to a single 35 
subtype at a time (6, 10, 14), the network-based approach allowed for analysis of multiple subtypes 36 
concurrently, leading to a substantial benefit in power. We found that pnMSM were more likely to 37 
be in peripheral positions in clusters and to link to each other. pnMSM were more likely to link MSM 38 
and heterosexuals of the opposite gender than were heterosexual women. Taken together, these 39 
differences in the reconstructed transmission network suggest differences in the transmission 40 
dynamics of pnMSM as compared to both MSM and heterosexual men. 41 
A limitation of this study was that the reconstruction method creates a network with more links than 42 
the true transmission network because the order of transmissions is difficult to resolve when 43 
successive infections occur close together in time. Sexual networks in which individuals became 44 
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infected within a short time will appear as fully connected clusters. For this reason, degree here is 1 
not solely related to the number of onward transmissions, but is also a measure of the speed of 2 
transmission within a group. In this context, the equivalent degree but peripheral positions of 3 
pnMSM suggest that they are involved in closely linked MSM sexual networks but transmit less 4 
between these sexual networks, and probably transmit less overall. These differences might reflect 5 
differences in the contact networks of pnMSM or differences in transmission. One explanation might 6 
be that they have a lower partner exchange rate, but another possibility is that they use condoms 7 
more consistently or have sex with lower risk partners. Linking to each other indicates that they may 8 
not find sexual partners in the same venues as MSM and/or seek out other nondisclosed MSM for 9 
sex. This finding is supported by interviews, with nondisclosed MSM in the USA (26) and men who 10 
have sex with men and women (MSMW) in the UK (22) reporting avoiding venues considered too 11 
public or openly gay, and is important because prevention messages displayed in these venues will 12 
not reach them. MSMW in NATSAL were less likely than MSM to visit sexual health clinics and to 13 
receive prevention there, despite similar rates of sexually transmitted infections, and nearly 50% had 14 
never been to a gay club (22). The Gay Men’s Sex Survey 2014 similarly found that bisexual and non-15 
gay identified men were 2.5 times less likely to have ever been tested for HIV (27).  16 
If nondisclosed MSM have sex with women, they may put female partners at risk. We found that 17 
self-reported heterosexual men more frequently linked MSM to heterosexual women than 18 
heterosexual women linked MSM to heterosexual men. This finding is surprising as men who report 19 
both male and female partners are classified as MSM in the database, so we expect linkage between 20 
MSM and women. However, the number of such potential transmission chains was small, only 54 in 21 
total (4% of all heterosexual men clustered in the network), in agreement with a model quantifying 22 
the extent of bisexual bridging in large cities in the USA (28).  In NATSAL data, MSMW reported 23 
unprotected sex with men and women, but lower rates of unprotected sex with men than those 24 
observed among MSM (22), which could explain why this sexual behaviour does not lead to more 25 
transmissions. 26 
The absence of women in clusters formed the basis of our procedure for identifying pnMSM. Our 27 
inclusion of clusters containing multiple self-reported heterosexuals enabled us to test whether 28 
pnMSM linked to each other. We did not analyse clusters involving only heterosexual men (n>200) 29 
because we cannot determine whether women are missing. Even among the clusters examined, we 30 
cannot exclude the possibility that female intermediaries are missing. The higher frequency of non-B 31 
subtypes, most common among heterosexuals, among pnMSM, could indicate that a proportion of 32 
them were in fact infected heterosexually. However, given that MSM and women are both 33 
diagnosed at much higher rates than heterosexual men (2), it is likely that our estimates of 34 
parameters relating to pnMSM remain conservative. If the additional >200 clusters containing only 35 
heterosexual men and >2500 clusters comprising only MSM had been included in the assortativity 36 
analysis, assortativity based on self-reported risk group would have been stronger but even with our 37 
conservative approach it was significant. 38 
Based on the proportion of individuals diagnosed with recent infections, pnMSM were not 39 
diagnosed later than MSM. In contrast, heterosexual men in the UK tend to be diagnosed later than 40 
MSM (2) thus pnMSM may be testing more regularly than heterosexual men. However, the number 41 
of individuals with recency test results was small, which may limit our ability to detect any 42 
difference. We previously found that pnMSM were more likely to be Black African than other 43 
heterosexuals (11) and here found that they were more likely to be Black African than the MSM they 44 
cluster with. These results are in agreement with findings from interviews with Black gay men in the 45 
UK, who are less likely to disclose their sexuality than White gay men (29).  46 
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Our results reinforce the need for prevention campaigns appropriate for nondisclosed MSM. They 1 
will not be reached by messages displayed in traditional gay venues if they do not frequent them and 2 
as a consequence may underestimate their own risk. Interventions that target risk behaviours 3 
without focusing on disclosure will be more effective; however, encouraging patients to build 4 
trusting relationships with their healthcare providers, in which they feel able to disclose their sexual 5 
behaviour, could be a valuable focus for Public Health. In parallel, our findings support the 6 
deployment of real-time HIV phylogenetic analyses for targeted public health responses (30). In this 7 
case, identification of pnMSM based on their position in networks could help tailor partner services 8 
interviews towards them, for example. Further investigation into the behaviour of nondisclosed 9 
MSM in the UK, in collaboration with social scientists, should be carried out to better tailor health 10 
promotion towards this group.  11 
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Tables 1 
Table 1: Risk group, sex, ethnicity and subtype of sequences clustered in the network as 2 
compared to the rest of the UK HIV database (UKdb).  3 
  UKDB NODES IN 
NETWORK 
OR (95% CI) P 
n  50025 14405 (28.8%)   
Risk group HET 17072 3084 (18.1%) Ref  
 MSM 23128 8452 (36.5%) 2.6 (1.6-4.3) <0.0001 
 Other/ NA 9825 2869 (28.8%) 0.9 (0.4-1.8)  
Sex F 11461 1881 (16.4%) Ref  
 M 31360 10305 (32.9%) 1.1 (0.8-1.4)  
Ethnicity Black 
African 
12136 1701 (14.0%) Ref  
 White 25092 8745 (34.9%) 1.9 (1.3-2.6) 0.0002 
 Other/ NA 12797 3959 (31.0%) 2.2 (1.5-3.2) <0.0001 
Subtype A1 2512 405 (16.1%) Ref  
 B 31649 11326 (35.8%) 2.8 (2.1-3.8) <0.0001 
 C 15864 2674 (16.9%) 1.0 (0.8-1.2)  
UKdb UK HIV Database, HET heterosexual, MSM men who have sex with men, NA not available, F 4 
female, M male, CI confidence Interval. 5 
Table 2: Ethnicity, HIV subtype, recency of infection and age of men who have sex with men 6 
(MSM) and potential nondisclosed MSM (pnMSM).  7 
  MSM pnMSM p 
n  955 249  
Ethnicity Black African 20 (2.1%) 42 (16.9%) <0.0001# 
 White 813 (85.1%) 147 (59.0%)  
 Other 114 (11.9%) 58 (23.3%)  
 NA 8(0.8%) 2(0.8%)  
Subtype A1 9 (1.0%) 4 (1.6%) 0.006# 
 B 922 (96.5%) 229 (92.0%)  
 C 24 (2.5%) 16 (6.4%)  
Recency Recent 236 (83.7%) 53 (84.1%) 1# 
 Established 46 (16.3%) 10 (15.9%)  
Age (mean +/- sd) 36.38 +/- 10.46 39.00 +/- 11.96 0.002+ 
# fisher’s exact test, + two sample t-test, NA not available 8 
Table 3: Centrality indicators for MSM and potential nondisclosed MSM (pnMSM). P values 9 
were calculated using a paired Wilcoxon signed rank test. 10 
 MSM (MEAN, 95%CI) PNMSM (MEAN, 95%CI) P-VALUE 
BETWEENNESS CENTRALITY 2.24 (0.98 – 3.51) 1.31 (0.48-2.15) 0.002* 
EIGENVECTOR CENTRALITY 0.52 (0.50 - 0.55) 0.50 (0.47 - 0.53) 0.039* 
DEGREE 3.02 (2.65 – 3.40) 2.83 (2.46 – 3.20) 0.073 
Note: statistical significance was calculated using a non-parametric paired Wilcoxon signed rank test 11 
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Figures 1 
Figure 1: Cartoon depicting the characteristic positions within men who have sex with men (MSM) 2 
clusters of potential nondisclosed MSM (pnMSM). Nodes are coloured by self-reported risk group. A. 3 
Based on betweenness and eigenvector, pnMSM tended to be on the periphery of clusters. B. Based 4 
on assortativity, pnMSM linked to each other in MSM clusters. C. Based on a brokerage analysis, 5 
heterosexual men were more likely to link MSM and heterosexual women then heterosexual 6 
females were to link MSM and self-reported heterosexual men. D. The brokerage analysis counts the 7 
number of occurrences of each of the two configurations in the network. 8 
 9 
Figure 2: Data processing flow chart showing the number of sequences at each stage of analysis. 10 
Only clusters comprising at least one UK sequence were counted in the RaxML tree. Percentages 11 
were calculated with the total number of sequences from that subtype as the denominator. GD: 12 
genetic distance, tMRCA: time to most recent common ancestor. 13 
12 
 
 1 
Figure 3: Clusters containing men who have sex with men (MSM) and heterosexual men. Clusters 2 
were selected if they contained no women and at least one heterosexual man and one MSM. Nodes 3 
are coloured by risk group with heterosexuals in orange and MSM in blue. Nodes in grey are those 4 
for which risk is unknown. All nodes represent men. 5 
 6 
13 
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Supplementary Figures 5 
 6 
Supplementary Figure 1: Cluster size distribution of the UK database HIV transmission 7 
network. 8 
  9 
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 1 
Supplementary Figure 2: Assortativity by self-reported risk group was calculated among the 2 
clusters (in turquoise). In parallel, risk group labels were randomised 10,000 times within 3 
clusters and assortativity was re-estimated in each network to generate a null distribution 4 
given risk group frequencies (in pink). 5 
 6 
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Supplementary Figure 31 
 2 
Supplementary Figure 3: Sample dates for the 50,025 individuals included in the study, 3 
broken down by month. 4 
 5 
Supplementary Tables 6 
Supplementary Table 1: Correlates of clustering and interaction between predictors in a 7 
multivariate logistic regression model 8 
  OR 95%CI (lower) 95%CI (upper) p 
Subtype B 2.8384*** 2.0962 3.8429 1.47E-11 
 C 0.9928 0.8152 1.2173 0.9438 
Sex Male 1.0846 0.8124 1.4405 0.5779 
Risk group PWID 0.9273 0.2297 3.0538 0.9073 
 MSM 2.6300*** 1.6119 4.2709 0.0001 
 Other/NA 0.875 0.3895 1.7543 0.7253 
Ethnicity Other/NA 2.1835*** 1.4882 3.1634 4.78E-05 
 White 1.8811*** 1.344 2.6122 0.0002 
Subtype/ Sex B/Male 1.4795* 1.0724 2.0476 0.0175 
 C/Male 1.2552 0.9364 1.6898 0.1309 
Subtype/ Risk group B/PWID 0.4349** 0.2399 0.8135 0.0073 
 C/PWID 1.123 0.556 2.311 0.7489 
 B/MSM 0.4136*** 0.2651 0.6455 0.0001 
 C/MSM 0.7259 0.4541 1.1611 0.1805 
 B/Other 1.4702 0.6787 3.5008 0.3528 
 C/Other 0.9131 0.4335 2.1142 0.8201 
Subtype/ Ethnicity B/Other 0.4709*** 0.3076 0.7277 0.0006 
 C/Other 0.8508 0.577 1.2679 0.4204 
 B/White 0.6342* 0.4331 0.9332 0.0200 
18 
 
 C/White 1.3528 0.9599 1.9185 0.0869 
Sex/ Risk group M/PWID 1.0662 0.756 1.5142 0.7172 
 M/MSM NA NA NA NA 
 M/Other 0.8306 0.5627 1.2304 0.3515 
Sex/ Ethnicity M/Other 0.7657 0.6016 0.974 0.0299 
 M/White 0.678*** 0.5438 0.8448 0.0005 
Risk group/ Ethnicity PWID/Other 1.5572 0.5203 5.7936 0.4610 
 MSM/Other 1.0848 0.7804 1.5116 0.6294 
 Other/Other 0.9384 0.5385 1.6213 0.8206 
 PWID/White 1.2976 0.4697 4.5893 0.6458 
 MSM/White 1.0646 0.784 1.4494 0.6895 
 Other/White 0.9772 0.5745 1.6595 0.9319 
Reference groups are not shown: subtype A1, female sex, heterosexuals, Black-African ethnicity. 1 
PWID people who inject drugs, MSM men who have sex with men, NA not available, CI confidence 2 
Interval. ***p<0.001, **p<0.01, *p<0.05 3 
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